Found 6412 matches for
Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance artemisinin-genetics-resistance. Hinxton, Cambridge, UK, 19 January 2015 – The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin.
Led by Chief Operating Officer (COO) David Burton (top right) and based in Bangkok, MORU's Operations & Administration team provides multifunctional support to Departments, Units and study sites across the MORU Tropical Health Network. In addition, HR & Training, Logistics, IT, Health & Safety, Compliance, Security, Communications, Finance, Admin, Legal / Research Services, Contracts and Funding teams based in the University of Oxford provide the MORU Network with valuable support, as do operations teams based in each MORU Unit.